3-(tert-Butyl)phenyl carbonochloridothioate | CAS:97986-06-6

We serve 3-(tert-Butyl)phenyl carbonochloridothioate CAS:97986-06-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-(tert-Butyl)phenyl carbonochloridothioate

Chemical Name:3-(tert-Butyl)phenyl carbonochloridothioate
CAS.NO:97986-06-6
Synonyms:3-(tert-Butyl)phenyl carbonochloridothioate
O-(3-tert-butylphenyl) chloromethanethioate
 
Physical and Chemical Properties:
Density 1.123 g/mL at 25ºC(lit.)
Boiling Point 309.4ºC at 760 mmHg
Molecular Formula C11H13ClOS
Molecular Weight 228.73800
Flash Point >230 °F
Exact Mass 228.03800
PSA 41.32000
LogP 3.88660
Index of Refraction n20/D 1.549(lit.)
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Use:Intermediate of Organic synthesis.



Contact us for information like 3-(tert-Butyl)phenyl carbonochloridothioate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,O-(3-tert-butylphenyl) chloromethanethioate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,O-(3-tert-butylphenyl) chloromethanethioate Use and application,O-(3-tert-butylphenyl) chloromethanethioate technical grade,usp/ep/jp grade.


Related News: Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”(2-(5-methoxy-1H-indol-3-yl)ethyl)phosphoramidic dichloride manufacturer Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”Sodium; 2-[((E)-3-phenyl-allyl)-hydrazono]-propionate supplier First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.Benzoic acid, 2,5-bis(phenylethynyl)- vendor First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.